Emergent Gets $628 Million of Warp Speed Work on Covid Vaccines

Published June 1, 2020

Emergent BioSolutions Inc. said it will carry out $628 million of work as part of the U.S. government’s Operation Warp Speed to accelerate the delivery of Covid-19 vaccines.

Related Stories